424 related articles for article (PubMed ID: 14676081)
1. Cutaneous melanomas associated with nevi.
Bevona C; Goggins W; Quinn T; Fullerton J; Tsao H
Arch Dermatol; 2003 Dec; 139(12):1620-4; discussion 1624. PubMed ID: 14676081
[TBL] [Abstract][Full Text] [Related]
2. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.
Banky JP; Kelly JW; English DR; Yeatman JM; Dowling JP
Arch Dermatol; 2005 Aug; 141(8):998-1006. PubMed ID: 16103329
[TBL] [Abstract][Full Text] [Related]
3. [Cutaneous melanoma associated with previous nevus].
Gutiérrez MP; Barengo M; Mainardi C; Garay I; Kurpis M; Ruiz Lascano A
Medicina (B Aires); 2009; 69(5):536-40. PubMed ID: 19897439
[TBL] [Abstract][Full Text] [Related]
4. Nevus-associated melanomas: clinicopathologic features.
Shitara D; Nascimento MM; Puig S; Yamada S; Enokihara MM; Michalany N; Bagatin E
Am J Clin Pathol; 2014 Oct; 142(4):485-91. PubMed ID: 25239415
[TBL] [Abstract][Full Text] [Related]
5. Etiologic and other factors predicting nevus-associated cutaneous malignant melanoma.
Purdue MP; From L; Armstrong BK; Kricker A; Gallagher RP; McLaughlin JR; Klar NS; Marrett LD;
Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):2015-22. PubMed ID: 16103454
[TBL] [Abstract][Full Text] [Related]
6. Dysplastic nevi in relation to superficial spreading melanoma.
Titus-Ernstoff L; Barnhill RL; Duray PH; Ernstoff MS; Kirkwood JM
Cancer Epidemiol Biomarkers Prev; 1993; 2(2):99-101. PubMed ID: 8467253
[TBL] [Abstract][Full Text] [Related]
7. Nodal melanocytic nevi in sentinel lymph nodes. Correlation with melanoma-associated cutaneous nevi.
Holt JB; Sangueza OP; Levine EA; Shen P; Bergman S; Geisinger KR; Creager AJ
Am J Clin Pathol; 2004 Jan; 121(1):58-63. PubMed ID: 14750241
[TBL] [Abstract][Full Text] [Related]
8. Outcome of patients with de novo versus nevus-associated melanoma.
Lin WM; Luo S; Muzikansky A; Lobo AZ; Tanabe KK; Sober AJ; Cosimi AB; Tsao H; Duncan LM
J Am Acad Dermatol; 2015 Jan; 72(1):54-8. PubMed ID: 25440436
[TBL] [Abstract][Full Text] [Related]
9. Histologic and epidemiologic correlates of P-MAPK, Brn-2, pRb, p53, and p16 immunostaining in cutaneous melanomas.
Richmond-Sinclair NM; Lee E; Cummings MC; Williamson R; Muller K; Green AC; Hayward NK; Whiteman DC
Melanoma Res; 2008 Oct; 18(5):336-45. PubMed ID: 18781132
[TBL] [Abstract][Full Text] [Related]
10. Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas.
Liu W; Dowling JP; Murray WK; McArthur GA; Thompson JF; Wolfe R; Kelly JW
Arch Dermatol; 2006 Dec; 142(12):1551-8. PubMed ID: 17178980
[TBL] [Abstract][Full Text] [Related]
11. [Expression of galanin in melanocytic tumors].
Gilaberte Y; Vera J; Coscojuela C; Roca MJ; Parrado C; González S
Actas Dermosifiliogr; 2007; 98(1):24-34. PubMed ID: 17374330
[TBL] [Abstract][Full Text] [Related]
12. Sun exposure, phenotypic characteristics, and cutaneous malignant melanoma. An analysis according to different clinico-pathological variants and anatomic locations (Italy).
Naldi L; Altieri A; Imberti GL; Gallus S; Bosetti C; La Vecchia C;
Cancer Causes Control; 2005 Oct; 16(8):893-9. PubMed ID: 16132799
[TBL] [Abstract][Full Text] [Related]
13. Dysplastic nevus in histologic contiguity with acquired nonfamilial melanoma. Clinicopathologic experience in a 100-bed hospital.
Duray PH; Ernstoff MS
Arch Dermatol; 1987 Jan; 123(1):80-4. PubMed ID: 3800426
[TBL] [Abstract][Full Text] [Related]
14. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
15. Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas.
Haenssle HA; Mograby N; Ngassa A; Buhl T; Emmert S; Schön MP; Rosenberger A; Bertsch HP
JAMA Dermatol; 2016 Mar; 152(3):291-8. PubMed ID: 26536613
[TBL] [Abstract][Full Text] [Related]
16. Dysplastic nevi in association with multiple primary melanoma.
Titus-Ernstoff L; Duray PH; Ernstoff MS; Barnhill RL; Horn PL; Kirkwood JM
Cancer Res; 1988 Feb; 48(4):1016-8. PubMed ID: 3338073
[TBL] [Abstract][Full Text] [Related]
17. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
Boyd AS; Shakhtour B; Shyr Y
J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
[TBL] [Abstract][Full Text] [Related]
18. Comparison between familial and sporadic cutaneous melanoma in Valencia, Spain.
Nagore E; Botella-Estrada R; Garcia-Casado Z; Requena C; Serra-Guillen C; Llombart B; Sanmartin O; Guillen C
J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):931-6. PubMed ID: 18355200
[TBL] [Abstract][Full Text] [Related]
19. Minimal deviation melanoma: a histologic variant of cutaneous malignant melanoma in its vertical growth phase.
Muhlbauer JE; Margolis RJ; Mihm MC; Reed RJ
J Invest Dermatol; 1983 Jun; 80 Suppl():63s-65s. PubMed ID: 6854057
[TBL] [Abstract][Full Text] [Related]
20. Favorable prognosis for malignant melanomas associated with acquired melanocytic nevi.
Friedman RJ; Rigel DS; Kopf AW; Lieblich L; Lew R; Harris MN; Roses DF; Gumport SL; Ragaz A; Waldo E; Levine J; Levenstein M; Koenig R; Bart RS; Trau H
Arch Dermatol; 1983 Jun; 119(6):455-62. PubMed ID: 6859885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
